Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn C Goldstein

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survivalMaggie C U Cheang, Diana O Treaba, Caroline H Speers, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimenNeil L Berinstein, Gregory T Wolf, Paul H Naylor, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Journal of the National Cancer Institute|November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 23, 2006
Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survivalMaggie C U Cheang, Diana O Treaba, Caroline H Speers, et al.
Cancer Immunology, Immunotherapy : CII|November 8, 2011
Increased lymphocyte infiltration in patients with head and neck cancer treated with the IRX-2 immunotherapy regimenNeil L Berinstein, Gregory T Wolf, Paul H Naylor, et al.
Breast Cancer Research and Treatment|October 4, 2007
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 casesDmitry A Turbin, Samuel Leung, Maggie C U Cheang, et al.
Journal of the National Cancer Institute|November 23, 2013
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31Katherine L Pogue-Geile, Chungyeul Kim, Jong-Hyeon Jeong, et al.
Pageof 2